Sensus Healthcare, Inc.

Sensus Healthcare, Inc.

SRTSยทNASDAQ

$3.09

-2.8%
HealthcareMedical - Devices

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

At a Glance

Live Snapshot
Market Cap$50.87M
EPS-0.4700
P/E Ratio-8.42
Earnings Date07/30/2026
Sensus Healthcare, Inc.

Sensus Healthcare, Inc. Fair Value Envelope

SRTS ยท NASDAQ

Our analysis suggests that SRTS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $3.09, this represents a potential HIDDEN relative to our calculated worth for Sensus Healthcare, Inc..

Intrinsic Value
Current Price: $3.09

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$4.4B
+ Cash & Equivalents$22.1M
Firm Value$4.5B
- Debt$680.0K
Equity Value$4.5B
/ Shares Outstanding16,440,036B
DCF Value$272
UNDERVALUED BY 8691%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$1.1M
$2.1M
$4.2M
$8.4M
$16.9M
$33.8M
$67.6M
$135.2M
$270.3M
$540.7M
Maintenance CapEx
-$78.4K
-$156.8K
-$313.6K
-$627.2K
-$1.3M
-$2.5M
-$5.0M
-$10.0M
-$20.1M
-$40.1M
Owner Earnings
$977.6K
$2.0M
$3.9M
$7.8M
$15.6M
$31.3M
$62.6M
$125.1M
$250.3M
$500.5M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$905.2K
$1.7M
$3.1M
$5.7M
$10.6M
$19.7M
$36.5M
$67.6M
$125.2M
$231.8M
Terminal Value represents 88.7% of Enterprise Value